Randi Fain

Randi Fain is the Vice President, Head of Medical Affairs at Neurocrine Biosciences. Randi has held similar positions at Mesoblast Limited, Amicus Therapeutics, and Mallinckrodt Pharmaceuticals. Prior to this, Randi worked as a Senior Director at Eisai Global Neuroscience Business Unit, where they were responsible for strategic oversight of medical affairs plans for various products. Randi also has experience as a Medical Director at Eisai Pharmaceuticals, Group Director at Zymes, and Senior Medical Director at Merck. Randi holds a MD from NYU Grossman School of Medicine, a Master of Science in Biomedical Ethics from Columbia University, and a Bachelor of Arts from Washington University in St. Louis.